| Identification | Back Directory | [Name]
LY-2922470 | [CAS]
1423018-12-5 | [Synonyms]
LY2922470
LY-2922470
LY 2922470,LY-2922470,LY2922470,Free Fatty Acid Receptor,inhibit,Inhibitor,FFAR
(3S)-3-[4-[[5-[(8-methoxy-3,4-dihydro-2H-quinolin-1-yl)methyl]-2-thienyl]methoxy]phenyl]hex-4-ynoic acid
(S)-3-(4-((5-((8-METHOXY-3,4-DIHYDROQUINOLIN-1(2H)-YL)METHYL)THIOPHEN-2-YL)METHOXY)PHENYL)HEX-4-YNOIC ACID
Benzenepropanoic acid, 4-[[5-[(3,4-dihydro-8-methoxy-1(2H)-quinolinyl)methyl]-2-thienyl]methoxy]-β-1-propyn-1-yl-, (βS)- | [Molecular Formula]
C28H29NO4S | [MDL Number]
MFCD30489363 | [MOL File]
1423018-12-5.mol | [Molecular Weight]
475.6 |
| Chemical Properties | Back Directory | [Boiling point ]
689.1±55.0 °C(Predicted) | [density ]
1.247±0.06 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMSO: ≥ 125 mg/mL (262.83 mM) | [form ]
Solid | [pka]
4.19±0.10(Predicted) | [color ]
Off-white to light yellow |
| Hazard Information | Back Directory | [Uses]
LY 2922470, has demonstrated potent, efficacious and durable dose dependent reduction in glucose levels along with significant increases in insulin and GLP-1 secretion during preclinical testing. It’s a novel, potent and Selective GPR40 Agonists for the treatment of type 2 Diabetes Mellitus. |
|
| Company Name: |
cjbscvictory
|
| Tel: |
13348960310 |
| Website: |
https://www.weikeqi-biotech.com/ |
|